Clinical trial
PROSPECTIVE MULTICENTER OBSERVATIONAL CLINICAL INVESTIGATION OF LUTEIN USE BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)
NCT06465342 is registered in ClinicalTrials.gov with OFFHEALTH S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROSPECTIVE MULTICENTER OBSERVATIONAL CLINICAL INVESTIGATION OF LUTEIN USE BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)
- Lead sponsor
- OFFHEALTH S.p.A.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 12, 2024
- Completion date
- December 12, 2025
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dml stage 3